Clinical utility of the revised international staging system in unselected patients with newly diagnosed and relapsed multiple myeloma

N. Tandon, S. V. Rajkumar, B. LaPlant, A. Pettinger, M. Q. Lacy, A. Dispenzieri, F. K. Buadi, M. A. Gertz, S. R. Hayman, N. Leung, R. S. Go, D. Dingli, P. Kapoor, Y. Lin, Y. L. Hwa, A. L. Fonder, M. A. Hobbs, S. R. Zeldenrust, J. A. Lust, W. I. GonsalvesS. J. Russell, S. K. Kumar

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

We analyzed the utility of Revised International staging system (RISS) in an unselected cohort of newly diagnosed multiple myeloma (NDMM; cohort 1), and relapsed/refractory multiple myeloma (RRMM; cohort 2) patients. Cohort 1 included 1900 patients seen within 90 days of diagnosis, from 2005 to 2015, while cohort 2 had 887 patients enrolled in 23 clinical trials at Mayo Clinic. The overall survival (OS) and progression-free survival (PFS) was calculated from the time since diagnosis or trial registration. The median estimated follow up was 5 and 2.3 years for Cohorts 1 and 2, respectively. Among 1067 patients evaluable in Cohort 1, the median OS and PFS was 10 and 2.8 years for RISS stage I, 6 and 2.7 years for RISS stage II and 2.6 and 1.3 years for RISS stage III (Po0.0001). Among 456 patients evaluable in Cohort 2, the median OS and PFS was 4.3 and 1.1 years for RISS stage I, 2 and 0.5 years for RISS stage II and 0.8 and 0.2 years for RISS stage III (Po0.0001). In conclusions, RISS gives a better differentiation of NDMM as well as RRMM patients into three survival subgroups and should be used to stratify patients in future clinical trials.

Original languageEnglish (US)
Article numbere528
JournalBlood cancer journal
Volume7
Issue number2
DOIs
StatePublished - 2017

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Clinical utility of the revised international staging system in unselected patients with newly diagnosed and relapsed multiple myeloma'. Together they form a unique fingerprint.

Cite this